SCHEMBL18501591

SCHEMBL18501591

C=C1CC[C@H]2C(=C)C(=O)O[C@@H]2C2[C@H]1CC(=O)[C@]21CC[C@]2(OC(=O)c3ccccc3)[C@@H]3[C@H]4OC(=O)C(=C)[C@@H]4CCC(=C)[C@@H]3C[C@@]21OC(=O)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ UBE2D3 P61077 2/20 0.37
▸ NLRP3 Q96P20 3/20 0.35
▸ OPRM1 P35372 2/20 0.32
▸ OPRK1 P41145 2/20 0.32
▸ PKM P14618 9/20 0.31
▸ ABCB1 P08183 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17214373 0.90 UBE2D3 (0.37) UBE2D3NLRP3PKMABCB1
SCHEMBL17214372 0.77 PKM (0.36) UBE2D3NLRP3PKM
SCHEMBL18506553 0.59 PKM (0.34) UBE2D3NLRP3PKM
SCHEMBL17214363 0.58 PKM (0.38) NLRP3PKM
SCHEMBL18501586 0.58 PKM (0.38) NLRP3PKM
Dehydrocostuslactone SCHEMBL936050 0.56 CYP19A1 (0.46) NLRP3PKM
SCHEMBL18501587 0.56 PKM (0.38) NLRP3PKM
Dehydrozaluzanin C SCHEMBL17214360 0.55 CYP19A1 (0.42) NLRP3PKM
SCHEMBL1426503 0.55 GAA (0.49) —
SCHEMBL22305507 0.54 PKM (0.41) UBE2D3NLRP3PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670226-B2 Sesquiterpenoids NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2017-06-06 — — US disclosed
US-9670226-B2 Sesquiterpenoids NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2017-06-06 — — US disclosed
US-20170044180-A1 Sesquiterpenoids NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2017-02-16 — — US disclosed
US-20170044180-A1 Sesquiterpenoids NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2017-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044180-A1 Sesquiterpenoids NFKBIA, RELA, IKBKG UBE2D3 954/4885NLRP3 192/4885OPRM1 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback